Patel; Zarna

Patent Applications and Registrations

Patent applications and USPTO patent grants for Patel; Zarna.The latest application filed is for "improved process of preparing mrna-loaded lipid nanoparticles".

Company Profile

8.3.13

Patel; Zarna - Lexington MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Improved Process Of Preparing Mrna-loaded Lipid Nanoparticles App 20220218612 - Karve; Shrirang ; et al.	2022-07-14
Process of preparing mRNA-loaded lipid nanoparticles Grant 11,357,726 - Karve , et al. June 14, 2	2022-06-14
TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF CODON-OPTIMIZED mRNA ENCODING CFTR App 20220160827 - Heartlein; Michael ; et al.	2022-05-26
Composition and Methods for Treatment of Primary Ciliary Dyskinesia App 20220087935 - Dias; Anusha ; et al.	2022-03-24
Dry Powder Formulations for Messenger RNA App 20210378977 - Karve; Shrirang ; et al.	2021-12-09
Treatment of cystic fibrosis by delivery of codon-optimized mRNA encoding CFTR Grant 11,173,190 - Heartlein , et al. November 16, 2	2021-11-16
Messenger Rna Therapy For The Treatment Of Friedreich's Ataxia App 20210187122 - Heartlein; Michael ; et al.	2021-06-24
Cationic Polymers App 20210113483 - DeRosa; Frank ; et al.	2021-04-22
Messenger RNA therapy for the treatment of Friedreich's ataxia Grant 10,780,183 - Heartlein , et al. Sept	2020-09-22
Composition And Methods For Treatment Of Primary Ciliary Dyskinesia App 20200215157 - Dias; Anusha ; et al.	2020-07-09
TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF NEBULIZED mRNA ENCODING CFTR App 20200157157 - KARVE; SHRIRANG ; et al.	2020-05-21
Process Of Preparing Mrna-loaded Lipid Nanoparticles App 20200085745 - Karve; Shrirang ; et al.	2020-03-19
Dry Powder Formulations For Messenger Rna App 20200022921 - Karve; Shrirang ; et al.	2020-01-23
Messenger Rna Vaccines And Uses Thereof App 20200016274 - Karve; Shrirang ; et al.	2020-01-16
Messenger Rna Therapy For The Treatment Of Friedreich's Ataxia App 20180369413 - Heartlein; Michael ; et al.	2018-12-27
TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF CODON-OPTIMIZED mRNA ENCODING CFTR App 20180333457 - Heartlein; Michael ; et al.	2018-11-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.